2Kojima M, Motoori T, Asano S, et al. Histological diversity of reactive and atypical proliferative lymph nocle lesions in systemic lupus erythematosus patients[J].Pathol Res Pract, 2007,203 (6) 423-431.
3Oksenhendler E, HIV associated multicentric Castleman disease [J]. Curr Opin HIV AIDS,2009 ,4(1):16-21.
4Coca S, Salas I, Martinez R, et al. Meningeal Castleman'sdis ease with multifocal involvement: a case report and review of lit erature[J]. Neurooncol,2008,88(1) 37- 41.
5Roca B. Castleman's Disease. A Review[J].AIDS Rev,2009,11 (1)3- 7.
6Starkey C, Joste N, Lee F. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide[J]. Am J Hematol, 2006,81(4) :303-304.
7Casper C, Krantz E, Corey L, et al. Valganciclovir for suppression of human herpesvirus 8 replication: a randomized, double blind, placebo controlled, crossover trial[J]. Infect Dis, 2008, 198(1):23- 30.
8Matsuyama M, Suzuki T, Tsubo H, etal. Anti- interleukin 6 re ceptor antibody(tocilizumab) treatment of multicentric Castle -man's disease[J]. Intern Med,2007,16(11)771- 774.
